MAXIDEX by Alcon is clinical pharmacology dexamethasone suppresses the inflammatory response to a variety of agents and it probably delays or slows healing. First approved in 1973.
Drug data last refreshed 18h ago
CLINICAL PHARMACOLOGY Dexamethasone suppresses the inflammatory response to a variety of agents and it probably delays or slows healing.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Comparison of Treatment With Preservative-free Dexamethasone 0.1% (Monofree Dexamethason) and Diclofenac 0.1% (Dicloabak) Eye Drops Versus Preserved Dexamethasone 0.1% (Maxidex) and Diclofenac 0.1% (Voltaren Ophtha) Eye Drops After Cataract Surgery
Systane Ultra Versus Maxidex Versus Saline
Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis
Worked on MAXIDEX at Alcon? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.